ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1874

Genomic Categories of Fatigue in Women with Fibromyalgia

Nada Lukkahatai1, Brian T. Walitt2, Majors Benjamin1, Gelio Alves3 and Leorey Saligan1, 1Intramural Research Program, National Institute of Nursing Research, National Institutes of Health, Bethesda, MD, 2Rheumatology, Washington Hospital Center, Washington, DC, 3National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Fatigue, fibromyalgia and genomics

  • Tweet
  • Email
  • Print
Session Information

Title: Fibromyalgia and Soft Tissue Disorders

Session Type: Abstract Submissions (ACR)

Background/Purpose:

FM is the chronic experience of body-wide pain, fatigue, cognitive dysfunction, and disordered sleep that occurs in the absence of any clear cause. Fatigue is a cause of significant morbidity and disability in FM. Most genomic studies in the FM population focus on pain symptoms. Only a few studies had investigated the fatigue experience in FM and no genomic studies investigated FM-specific fatigue symptoms. The purpose of this study is to identify genomic categories of fatigue in fibromyalgia (FM) and describe behavioral characteristics of these fatigue categories.

Methods: Under an active Medstar Research Institute protocol, FM participants diagnosed by 2010 diagnostic criteria and pain-free, race, age, and gender-matched controls were enrolled in the study. Participants completed questionnaires. RNA from peripheral blood samples collected using Paxgene tubes® were analyzed for differential gene expression using microarray technology with Affymetrix GeneChip® human genome U133 Plus 2.0. Cluster analysis was used to determine genotypic categories. The differences of symptoms between two clusters were analyzed by the analysis of variance (ANOVA).

Results: Thirty one Caucasian women diagnosed with FM, experiencing significant fatigue (MFI-general fatigue ≥ 13) and 20 pain and fatigue free, age-, race-, gender-matched controls were enrolled. Microarray data showed differential upregulated expression of centromere protein K (CENPK) gene after the probesets passed filtering criteria of 1% false discovery rate (FDR) and a slope of > log2 (over 2.0-fold change, p < 0.05). This CENPK gene is related to centromere function. Cluster analysis was conducted on the expressed genes from FM subjects which revealed two distinct clusters. Forty nine genes were differentially expressed over 2-fold change (p < 0.05) between the two clusters. One cluster showed significantly higher pain interference (p = 0.028) and higher depression (p = 0.027). Genes that upregulated in the high pain interference and high depression cluster include genes related to immune response, iron absorption and GABA transport. Genes related to calcium iron binding were differentially expressed in the other FM cluster with lower pain interference and depression.

Conclusion: Within FM women with high fatigue, there appears to be two distinct patterns of gene expression. These genomic patterns correspond with differences in behavioral characteristics. Further investigation of these genomic patterns may provide some insights into the mechanisms behind the relationship of fatigue with other FM behavioral symptoms.


Disclosure:

N. Lukkahatai,
None;

B. T. Walitt,
None;

M. Benjamin,
None;

G. Alves,
None;

L. Saligan,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genomic-categories-of-fatigue-in-women-with-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology